Viewing StudyNCT00255346



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00255346
Status: COMPLETED
Last Update Posted: 2023-12-18
First Post: 2005-11-16

Brief Title: Dasatinib as Therapy for Myeloproliferative Disorders MPDs
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Agnogenic Myeloid Metaplasia
Myelofibrosis
Hypereosinophilic Syndrome
Polycythemia Vera
Mastocytosis
Leukemia Myelomonocytic Chronic
Keywords:
Name View
CMML View
targeted therapy View
leukemia View
Acute myeloid leukemia AML View
Myelodysplastic syndrome MDS View
Agnogenic myeloid metaplasia - myelofibrosis MMM View
Hypereosinophilic syndrome HES View
Polycythemia vera PV View
Mastocytosis View